These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8637219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. All-trans retinoic acid potentiates the inhibitory effects of interferon alpha on chronic myeloid leukemia progenitors in vitro.
    Mahon FX, Chahine H, Barbot C, Pigeonnier V, Jazwiec B, Reiffers J, Ripoche J.
    Leukemia; 1997 May; 11(5):667-73. PubMed ID: 9180290
    [Abstract] [Full Text] [Related]

  • 4. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
    Robak T, Korycka A.
    Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
    [Abstract] [Full Text] [Related]

  • 5. The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.
    Marley SB, Deininger MW, Davidson RJ, Goldman JM, Gordon MY.
    Exp Hematol; 2000 May; 28(5):551-7. PubMed ID: 10812245
    [Abstract] [Full Text] [Related]

  • 6. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
    Gordon MY, Marley SB, Lewis JL, Davidson RJ, Nguyen DX, Grand FH, Amos TA, Goldman JM.
    J Clin Invest; 1998 Aug 15; 102(4):710-5. PubMed ID: 9710439
    [Abstract] [Full Text] [Related]

  • 7. Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: increased inhibition by all-trans- and 13-cis-retinoic acids in advanced stage disease.
    Sagayadan GE, Wiernik PH, Sun N, Ahearn G, Thompson D, Hallam SJ, Hu XP, Dutcher JP, Gallagher RE.
    Leuk Res; 1994 Oct 15; 18(10):741-8. PubMed ID: 7934131
    [Abstract] [Full Text] [Related]

  • 8. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma.
    Bellucci R, Sala R, De Propris MS, Cordone I, de Fabritiis P.
    Leuk Lymphoma; 1999 Nov 15; 35(5-6):471-81. PubMed ID: 10609784
    [Abstract] [Full Text] [Related]

  • 9. Effect of retinoic acid treatment on cytogenetic remission of chronic myeloid leukaemia.
    Egyed M, Kollár B, Rumi G, Keller E, Vass J, Fekete S.
    Acta Haematol; 2003 Nov 15; 109(2):84-9. PubMed ID: 12624492
    [Abstract] [Full Text] [Related]

  • 10. Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro' growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors.
    Visani G, Russo D, Ottaviani E, Tosi P, Damiani D, Michelutti A, Manfroi S, Baccarani M, Tura S.
    Leukemia; 1997 May 15; 11(5):624-8. PubMed ID: 9180282
    [Abstract] [Full Text] [Related]

  • 11. Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemia.
    Wandl UB, Niederle N, Kranzhoff M, Seeber S.
    Int J Cell Cloning; 1992 Sep 15; 10(5):292-8. PubMed ID: 1453016
    [Abstract] [Full Text] [Related]

  • 12. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Sep 15; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 13. Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.
    Sacchi S, Kantarjian HM, Freireich EJ, O'Brien S, Cortes J, Rios MB, Kornblau S, Giles FJ, Koller C, Gajewski J, Talpaz M.
    Leuk Lymphoma; 1999 Nov 15; 35(5-6):483-9. PubMed ID: 10609785
    [Abstract] [Full Text] [Related]

  • 14. A differential sensitivity to recombinant human interferon-alpha 2a between normal and chronic myeloid leukaemic peripheral blood granulocyte-macrophage colony-forming units.
    Gronthos S, To LB, Haylock DN, Juttner CA.
    Leuk Res; 1992 Nov 15; 16(2):153-8. PubMed ID: 1545568
    [Abstract] [Full Text] [Related]

  • 15. Interaction of 2-chlorodeoxyadenosine in combination either with interferons or recombinant human tumor necrosis factor alpha on myeloid progenitor cells in vitro.
    Korycka A, Robak T.
    Arch Immunol Ther Exp (Warsz); 1996 Nov 15; 44(4):259-64. PubMed ID: 9017167
    [Abstract] [Full Text] [Related]

  • 16. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
    Nara N.
    Leuk Lymphoma; 1993 Jun 15; 10(3):201-7. PubMed ID: 7693101
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).
    Dutcher JP, Lee S, Gallagher RE, Makary AZ, Hines JD, Londer H, Farnen JP, Bennett JM, Paietta E, Rowe JM, Goloubeva O, Wiernik PH, Eastern Cooperative Oncology Group.
    Leuk Lymphoma; 2005 Mar 15; 46(3):377-85. PubMed ID: 15621827
    [Abstract] [Full Text] [Related]

  • 18. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D, Goldschmitt J, Aulitzky WE, Huber C, Peschel C.
    Exp Hematol; 1995 Dec 15; 23(14):1431-8. PubMed ID: 8542928
    [Abstract] [Full Text] [Related]

  • 19. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors.
    Piacibello W, Sanavio F, Severino A, Morelli S, Vaira AM, Stacchini A, Aglietta M.
    Cancer Res; 1990 Aug 15; 50(16):5065-71. PubMed ID: 1696165
    [Abstract] [Full Text] [Related]

  • 20. Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid.
    Imaizumi M, Sato A, Koizumi Y, Inoue S, Suzuki H, Suwabe N, Yoshinari M, Ichinohasama R, Endo K, Sawai T.
    Leukemia; 1994 Aug 15; 8(8):1301-8. PubMed ID: 7520101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.